BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19504083)

  • 1. Financial requirements for the treatment of diabetes in Latin America: implications for the health system and for patients in Mexico.
    Arredondo A; de Icaza E
    Diabetologia; 2009 Aug; 52(8):1693-5. PubMed ID: 19504083
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cost of diabetes mellitus in Spain].
    González P; Faure E; Del Castillo A;
    Med Clin (Barc); 2006 Nov; 127(20):776-84. PubMed ID: 17198665
    [No Abstract]   [Full Text] [Related]  

  • 3. Measuring the burden of preventable diabetic hospitalisations in the Mexican Institute of Social Security (IMSS).
    Lugo-Palacios DG; Cairns J; Masetto C
    BMC Health Serv Res; 2016 Aug; 16():333. PubMed ID: 27484124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy.
    Barquera S; Campos-Nonato I; Aguilar-Salinas C; Lopez-Ridaura R; Arredondo A; Rivera-Dommarco J
    Global Health; 2013 Feb; 9():3. PubMed ID: 23374611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Direct service costs of diabetes mellitus hospitalisations in the Mexican Institute of Social Security].
    Salas-Zapata L; Palacio-Mejía LS; Aracena-Genao B; Hernández-Ávila JE; Nieto-López ES
    Gac Sanit; 2018; 32(3):209-215. PubMed ID: 27495830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The financial and health burden of diabetic ambulatory care sensitive hospitalisations in Mexico.
    Lugo-Palacios DG; Cairns J
    Salud Publica Mex; 2016; 58(1):33-40. PubMed ID: 26879505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers.
    Barcelo A; Arredondo A; Gordillo-Tobar A; Segovia J; Qiang A
    J Glob Health; 2017 Dec; 7(2):020410. PubMed ID: 29163935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic imperative to conquer diabetes.
    Fradkin J; Rodgers GP
    Diabetes Care; 2008 Mar; 31(3):624-5. PubMed ID: 18308686
    [No Abstract]   [Full Text] [Related]  

  • 9. Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico.
    Arredondo A; Zúñiga A; Parada I
    Public Health; 2005 Aug; 119(8):711-20. PubMed ID: 15885723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How should developing countries manage diabetes?
    Narayan KM; Zhang P; Williams D; Engelgau M; Imperatore G; Kanaya A; Ramachandran A
    CMAJ; 2006 Sep; 175(7):733. PubMed ID: 17001048
    [No Abstract]   [Full Text] [Related]  

  • 11. The economic burden of out-of-pocket medical expenditures for patients seeking diabetes care in Mexico.
    Arredondo A; Barceló A
    Diabetologia; 2007 Nov; 50(11):2408-9. PubMed ID: 17879080
    [No Abstract]   [Full Text] [Related]  

  • 12. [Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study].
    Köster I; Hauner H; von Ferber L
    Dtsch Med Wochenschr; 2006 Apr; 131(15):804-10. PubMed ID: 16607599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cost of diabetes in Latin America: evidence from Mexico].
    Arredondo A; De Icaza E
    Value Health; 2011; 14(5 Suppl 1):S85-8. PubMed ID: 21839907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America.
    Arredondo A; Azar A; Recamán AL
    Glob Public Health; 2018 Jul; 13(7):780-787. PubMed ID: 28447537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of hepatitis B infection among patients with diabetes.
    Deshpande G; Klink AJ; Shenolikar R; Singer J; Eisenberg Lawrence DF; Krishnarajah G
    Hum Vaccin Immunother; 2016 May; 12(5):1132-40. PubMed ID: 27050021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase of diabetes care at the verge of paradigm shift.
    Yang WS
    J Formos Med Assoc; 2019 Nov; 118 Suppl 2():S63-S65. PubMed ID: 31564386
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to commentary on costs of diabetes and its complications in Poland.
    Leśniowska J
    Eur J Health Econ; 2015 Mar; 16(2):227. PubMed ID: 25487550
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary to: Costs of diabetes and its complications in Poland.
    Fayaz-Bakhsh A; Sarvari Mehrabad R
    Eur J Health Econ; 2015 Mar; 16(2):225-6. PubMed ID: 25355296
    [No Abstract]   [Full Text] [Related]  

  • 19. [Financial requirements for health services demands for diabetes and hypertension in Mexico: 2001-2003].
    Arredondo A
    Rev Invest Clin; 2001; 53(5):422-9. PubMed ID: 11795108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of diabetes mellitus on healthcare costs in Italy.
    Giorda CB; Manicardi V; Diago Cabezudo J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.